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Effects of various culture conditions on lovastatin production were investigated in Aspergillus terreus
(KM017963) grown under solid state fermentation with wheat bran. Lovastatin production was influ-
enced by various physical factors such as pH, temperature, and nutritional factors such as carbon, ni-
trogen, metal ions/salts etc. Our study established that an initial pH of 6.0, growth temperature of 28 C
e30 C, inoculum size of 108 spores/mL as the optimal physiological culture conditions for maximal
production of lovastatin by A. terreus (KM017963). The carbon sources, glucose or dextrin when sup-
plemented at 3% (w/w) enhanced lovastatin production by five fold when supplemented as individual
component in wheat bran. Addition of metal salts such as CuSO4 (8%), FeSO4 (8%), CaCl2 (10%), NaCl (6%)
and MgSO4 (6%) enhanced the production by five fold. Supplementation with nitrogen sources, amino
acids, hydrocarbons, surfactants and amino acids did not have any profound effect on lovastatin
production.
Copyright © 2016 Institut Pertanian Bogor. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Lovastatin (C24H36O5), a fungal secondary metabolite, acts as
one of the competitive inhibitors of the enzyme hydroxyl methyl
glutaryl coenzyme A (HMG-CoA) reductase, which catalyses the
conversion of HMG-CoA to mevalonate during cholesterol biosyn-
thesis. Inhibition of HMG-CoA reductase, during cholesterol
biosynthesis leads to the accumulation of HMG-CoA which is
metabolized to simple compound and no lipophilic intermediates
are noted (Saleem et al. 2013).
Lovastatin is the world's widely prescribed drug to combat
hypercholesterolaemia, and was the first statin drug which was
approved by United States Food and Drug Administration in the
year 1987 (Radha and Lakshmanan 2013). In addition to reducing
cholesterol level, lovastatin has been reported to possess anti-
cancer property, immuno-modulatory role, anti-inflammatory ac-
tivity and also plays a role in prevention of neurological disorders,
bone disorders etc (Morimoto et al. 2006; Seenivasan et al. 2008;
Barrios and Miranda 2010).n).
nian Bogor.
r. Production and hosting by ElsIndustrial production of lovastatin by fungi was previously
achieved by employing submerged fermentation (SmF). Commer-
cial production of lovastatin is carried out by using Aspergillus ter-
reus. In addition to Aspergillus sp, Penicillium sp, Monascus sp,
Paecilomyces sp, Trichoderma sp, Pleurotus sp, Scopulariopsis sp etc
are reported as lovastatin producers (Bizukojc and Ledakowicz
2009; Upendra et al. 2013).
SmF is the cultivation of microorganisms in liquid nutrient
broth. Selected microorganisms are grown in closed environment
containing a rich broth of nutrients (the fermentationmedium) and
a high concentration of oxygen. SmF is generally accomplished in
batch or continuous culture system. Solid state fermentation (SSF)
is defined as the growth ofmicrobes in solid substrates without free
flowing aqueous phase. Substrates such as bran, bagasse, vegetable
wastes etc are the potential substrates for production of pharma-
ceutically important bioactive compounds (Renge et al. 2012).
Of late, SSF technology is being adapted because of several
merits of SSF over SmF. Solid substrates as fermentable sources are
tested owing to their low prices, eco-friendly approach, perennial
availability, low polluting effluents and easier downstream pro-
cessing (Praveen and Savitha 2012). In general, several cheaply
available agro wastes are reportedly being used as substrates for
production of pharmaceutically important metabolites (Osman
et al. 2011; Jahromi et al. 2012). Despite its limitations such asevier B.V. This is an open access article under the CC BY-NC-ND license (http://
Optimial conditions for maximal lovastatin production 175chances of contamination, low degree of aeration due to high solid
concentration, SSF can lead to significant increase in yield (Mienda
et al. 2011).
Screening and evaluation of nutritional and environmental re-
quirements of microorganism is an important initial step for bio-
process development for any metabolite under SmF or SSF.
Traditional methods of optimization involve supplementation of
solid substrates with various C/N/trace elements/surfactants
(Pandey et al. 2001). The main aim of the present study was to
evaluate various environmental and physiological parameters so as
to establish optimum growth conditions for the maximum pro-
duction of lovastatin by the soil isolate A. terreus (KM017963) by
SSF.
2. Materials and Methods
2.1. Screening of substrates
Numerous substrates [wheat bran, corn kernel, corn cob, corn
peel, potato skin, litchi peel, ashgourd seed, orange peel, tamarind
shell, groundnut shell, groundnut cake, coconut cake, sooji, rice
husk, carrot, saw dust, sugarcane bagasse, green gram bran, gram
husk, ragi bran, sesame seeds, Averrhoa bilimba, sago, sweet potato,
coffee husk, pea peel, mosambi skin, Psyllium husk, red rice(whole)
and red rice (broken)] were screened for lovastatin production. The
spore count was done using haemocytometer. The moisture con-
tent was maintained at 70% by adding 1.4 mL of sterile distilled
water having 107/8 spores/mL, to 2 g of substrate. The flasks were
then incubated at 28 C for 8 days (Jaivel and Marimuthu 2010).
2.2. Extraction
After 8 days of incubation, the solid substrate was dried at 40 C
for 24 hours, gently crushed and extracted with 10 mL of ethyl
acetate by shaking at 180 rpm for 2 hours followed by filtration
through Whatman No. 1 paper. to One mL of 1% trifluoroacetic acid
was added to 1 mL of extract and incubated for 10 minutes (lac-
tonization of hydroxyl acid form of lovastatin). The filtrate was then
spotted onto thin layer chromatography (TLC) for identifying
lovastatin in crude extract along with an authentic lovastatin
reference standard (Reddy et al. 2011).
2.3. Thin layer chromatography
The extracted organic phase was concentrated to about 50 mL
using a block heater adjusted to 45 C and applied to a heat acti-
vated 20  20 mm silica gel TLC plates. Dichloromethane and ethyl
acetate (70:30, v/v) were used as mobile phase. All the plates were
observed under a hand-held ultraviolet lamp (254 nm) after
developing thrice in the same mobile phase and exposed to iodine
vapour. For each TLC run, lovastatin authentic standard (Merck,
KGaA, Darmstat) was spotted for retention factor (Rf) value com-
parison and confirmation (Praveen et al. 2014).Table 1. Additional parameters tested for lovastatin production in solid state fermentati
Parameters Variable te
pH 4.0, 6.0, 7.0
Temperature 25 C, 28 C
Particle size 0.5 cm, 0.2
Initial moisture 60%, 70% an
Inoculum size 104 107/10
Hydrocarbons (butyrolactone, dodecane) 0.1%e0.3%
Metal ions 10%e40%
Surfactants (Tween-20, Tween-80) 10%e40%
Amino acids (methionine, histidine and glycine) 10%e40%
Sodium acetate 10%e40%2.4. High performance liquid chromatography
For high performance liquid chromatography, a C18 column
(250 mm  4.6 mm  5 mm internal diameter) with diode array
detector was used. Acetonitrile and water (acidified with 1.1%
phosphoric acid) (70:30 v/v) were used as mobile phase. The eluent
flow rate was maintained at 1.5 mL/minute and detection carried
out at 238 nm with injection volume of 20 mL (Samiee et al. 2003).
The production of lovastatin is expressed in mg/g dry weight sub-
strate (DWS). The yield of lovastatin was calculated (Muthumary
and Sashirekha 2007). Mevinolin (M2147) (Sigma-Aldrich, Srpuce
Street, St. Louis, USA) was used as standard.2.5. Optimization studies
Unless otherwise stated, wheat branwas used as a sole source of
carbon for lovastatin production. Two grams of wheat bran was
used with a relative humidity (RH) of 70%. One millilitre of spore
suspension (107/8 mL spores) of A. terreus (KM017963) was added to
the sterilized substrate and incubated at 28 C for 8 days (Jaivel and
Marimuthu 2010).2.5.1. Effect of carbon sources
Eleven different carbon sources (glucose, lactose, maltose,
fructose, sucrose, starch, carboxymethyl cellulose, dextrin, xylose,
mannitol and cellulose) were used to assess for their influence on
lovastatin production by A. terreus KM017963. Each carbon source
was tested at different concentrations ranging from 1% to 5% by
supplementing them in wheat bran. The inoculated flasks were
incubated for 8 days at 30 C. At the end of the incubation period
the yield of lovastatin was determined as mentioned previously.2.5.2. Effect of nitrogen sources
Seven nitrogen sources were tested for their effect on lovastatin
production (ammonium molybdate, ammonium oxalate, ammo-
nium sulphate, ammonium nitrate, yeast extract, malt extract and
peptone). The concentrations used were from 1% to 5% by supple-
menting them in wheat bran. The inoculated flasks were incubated
for 8 days at 30 C and lovastatin yield was determined.
In addition, the following physical and physiological parameters
were also tested at different concentrations to determine the
optimal concentration for each (Table 1).2.6. Statistical analysis
All experiments were done in triplicates and statistical analysis
were performed by using SPSS version 20. The statistical differ-
ence between mean values were accessed by one way analysis of
variance through Scheffe post hoc test at significance level
(p < 0.05).on.
sted Reference
and 8.0 (Chanakya et al. 2011)
, 30 C and 35 C (Chanakya et al. 2011)
5 cm and fine powder (Jahromi et al. 2012)
d 80% (Chanakya et al. 2011)
8 spores (Chanakya et al. 2011)
(Bizukojc and Ledakowicz 2009)
(Jia et al. 2010)
(Bizukojc and Ledakowicz 2009)
(Osman et al. 2011)
(Osman et al. 2011)
Table 2. List of substrates used to screen lovastatin for production in Aspergillus
terreus (KM017963).
Sl. No. Substrates HPLC yield (mg/g DWS)
1 Corn kernel 0.128
2 Corn cob UD*
3 Corn peel UD*
4 Potato skin 0.144
5 Litchi peel UD
6 Ashgourd seed UD*
7 Orange peel UD*
8 Tamarind shell UD*
9 Groundnut shell UD*
10 Groundnut cake UD*
11 Coconut cake UD
12 Sooji 0.200
13 Wheat bran 1.000
14 Rice husk UD*
15 Carrot NG
16 Saw dust UD*
17 Sugarcane bagasse UD*
18 Green gram bran UD*
19 Gram husk UD*
20 Ragi bran UD*
21 Sesame seeds UD*
22 Averrhoa bilimba UD*
23 Sago UD*
24 Sweet potato UD*
25 Coffee husk UD*
26 Pea peel UD*
27 Mosambi skin UD*
28 Psyllium husk NG
29 Broken red rice 0.001
30 Red rice(whole) 0.330
DWS¼ dry weight substrate; HPLC ¼ high performance liquid chromatography; UD
and UD*¼ Undetectable level, NG and NG*¼ No growth.
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Various environmental and nutritional parameters are known
to exhibit significant impact on yield of secondary metabolites.
Additional nutrients to the native solid substrates, sometimes, if
not always, influence the production of certain metabolites by
acting as an inducer (VanderMolen et al. 2013). We identified a
soil isolate, A. terreus (KM017963) as a potent lovastatin producing
strain out of 360 fungi screened (Praveen et al. 2014). Amongst the
30 substrates screened, wheat bran showed the highest yield of
lovastatin (1.00 mg/g DWS) (Table 2) when compared to other
substrates selected for growth and hence chosen for optimization
studies.Figure 1. Effect of carbon sources on lovastatin production in A. terreus (L1). Control: 2 g of w
size. CMC ¼ carboxymethyl cellulose; DWS ¼ dry weight substrate.In this study, we report various environmental and nutritional
parameters for the optimum production of lovastatin by SSF using
wheat bran as control at 30 C, 70% RH, coarse particle size which
yielded 1.00 mg/g DWS of lovastatin without addition of any sup-
plements (Praveen et al. 2014).
3.1. Effect of carbon and nitrogen sources
Our data on the effect of carbon sources as supplement to wheat
bran indicated that the simple carbon sugars, glucose and the
polysaccharide dextrin influenced lovastatin production in
A. terreus (KM017963). Optimal concentration of these inducers
was investigated by varying the concentration from 1% to 5% and
maximum lovastatin production was observed at 3% and at 2% of
glucose and dextrin, respectively as compared to control (Figure 1).
The effect of various nitrogen sources, that is, ammonium
molybdate, ammonium oxalate, ammonium sulphate, ammonium
nitrate, yeast extract, malt extract and peptone (1%, 2%, 3%, 4% and
5%w/v) on lovastatin productionwas studied. Each component was
added at 1%e5% w/v to wheat bran. None of the nitrogen sources
showed positive effect on lovastatin production in A. terreus
(KM017963) (data not shown). These nitrogen sources rather
influenced the growth of organisms thereby leading to increase in
biomass only.
3.2. Effect of pH and temperature
Maximum lovastatin production (3.60mg/g DWS) was observed
in substratewith pH 6.0 and substantial decrease in productionwas
observed above and below the pH 6.0 (Figure 2).
As far as temperature is concerned, lovastatin production was
found to be optimum at 28 C and 30 C with a yield of 1.20 and
1.4 mg/g DWS, respectively (Figure 3). Further increase or decrease
in temperature lead to poor production of lovastatin.
3.3. Effect of moisture, inoculum size and particle size
Among the several factors that are important for microbial
growth and metabolite production under SSF by using a particular
substrate, moisture content or water activity, inoculum size and
particle size are the most critical factors, which determine the
biomass and product formation in fermentation process (Pandey
et al. 2001). Highest lovastatin yield (3.50 mg/g DWS) in A. terreus
(KM017693) was observed at 60% moisture content (Figure 4).
In A. terreus (KM017963) the optimum inoculum size was found
to be 108 spores/mLwhich gave a yield of 3.60mg/g DWS (Figure 5).heat bran with relative humidity of 70%, pH 7.0, 107/8 spores/mL, 28 C, 0.5 cm particle
Figure 2. Effect of pH on lovastatin production in A. terreus (L1). Control: 2 g of wheat
bran with relative humidity of 70%, pH 7.0, 107/8 spores/mL, 28 C, 0.5 cm particle size.
DWS ¼ dry weight substrate.
Figure 4. Effect of moisture content on lovastatin production in A. terreus (L1). Control:
2 g of wheat bran with relative humidity of 70%, pH 7.0, 107/8 spores/mL, 28 C, 0.5 cm
particle size. DWS ¼ dry weight substrate.
Figure 5. Effect of initial inoculum size on lovastatin production in A. terreus (L1). Low:
104 spores/mL; medium: 108 spores/mL; high: 1010 spores/mL. Control: 2 g of wheat
bran with relative humidity of 70%, pH 7.0, 107/8 spores/mL, 28 C, 0.5 cm particle size.
DWS ¼ dry weight substrate.
Optimial conditions for maximal lovastatin production 177Higher inoculum volume (1010 spores/mL) leads to decreased
lovastatin production when compared to 108 spores/mL. With low
inoculum volume (104 spores/mL), the lovastatin yield (0.1 mg/g
DWS) is low because of less biomass resulting in decreased levels of
lovastatin.
The particle size also generally influences lovastatin production.
Maximum lovastatin production (3.60 mg/g DWS) was observed
withmedium sized (0.25mm)wheat branwhereas the fine particle
size (0.1 mm) and coarse sized (0.50 mm) (Figure 6) wheat bran did
not influence the growth and production of lovastatin in A. terreus
(KM017963).
3.4. Effect of metal ions, hydrocarbons and surfactants
Our study also confirmed the positive effect of metal ions as
individual components on lovastatin production in A. terreus
(KM017963). Sodium chloride, copper sulphate, calcium chloride,
ferrous sulphate and magnesium sulphate as individual compo-
nents at 6%, 8% and 10% enhanced the lovastatin yield by minimum
of five fold (5.0e6.5mg/g DWS) (Figure 7). However combination of
metal salts tested did not favour lovastatin production.
Our study did not show any marked increase in lovastatin yield
with any of the hydrocarbon or surfactant incorporated (Figure 8).
3.5. Effect of amino acid and sodium acetate
Sodium acetate showed no positive effect on lovastatin pro-
duction in A. terreus (KM017963) (Figure 9) and addition of aminoFigure 3. Effect of temperature on lovastatin production in A. terreus (L1). Control: 2 g
of wheat bran with relative humidity of 70%, pH 7.0, 107/8 spores/mL, 28 C, 0.5 cm
particle size. DWS ¼ dry weight substrate.acids such as methionine, histidine and glycine did not show any
positive effect on lovastatin production (Figure 10).
4. Discussion
In recent years, researchers have focused much on SSF for
commercial production of industrially important metabolites.
Wheat bran is generally considered as a complete solid substrateFigure 6. Effect of particle size on lovastatin production in A. terreus (L1). Control: 2 g
of wheat bran with relative humidity of 70%, pH 7.0, 107/8 spores/mL, 28 C, 0.5 cm
particle size. DWS ¼ dry weight substrate.
Figure 7. Effect metal ions on lovastatin production in A. terreus (L1). Control: 2 g of wheat bran with relative humidity of 70%, pH 7.0, 107/8 spores/mL, 28 C, 0.5 cm particle size.
DWS ¼ dry weight substrate.
P.V. Kamath, et al178for growth and metabolite production of microbes consisting of
protein, fats and polysaccharides such as arabinoxylans, cellulose
and lignin, but, however, lacks readily soluble sugars (Stevenson
et al. 2012). The aim of the present work was to study the in-
fluence of few growth supplements such as readily soluble
sugars, nitrogen, metal salts, surfactants etc.
In the present study, of 11 carbon sources tested, glucose and
dextrin at 3% and 2% respectively, gave the highest yield of lova-
statin. It is obvious that glucose being a readily soluble mono-
saccharide gets metabolized by the fungal isolates rather quickly
although interestingly, dextrin, a low molecular weight carbohy-
drate derived from the hydrolysis of starch seems to induce the
production of lovastatin. Lactose did not increase lovastatin pro-
duction in our study although it is reported previously that addition
of lactose to solid substrate has positive effect on lovastatin pro-
duction (Chanakya et al. 2011). On the contrary, none of theFigure 8. Effect of hydrocarbons and surfactants on lovastatin production in A. terreus (L1). C
0.5 cm particle size. DWS ¼ dry weight substrate.disaccharides used in our study had any positive effect on lovastatin
production. Generally, nitrogen sources (organic and inorganic)
have a vital role in increasing lovastatin production. Yeast extract
and sodium nitrate are shown to have significant impact on
increasing lovastatin production (Xu et al. 2005; Chanakya et al.
2011). However, none of the nitrogen sources (organic and inor-
ganic) tested with A. terreus (KM017963) showed any effect on
increasing lovastatin production.
Physical factors such as temperature, pH, moisture content,
inoculum volume and particle size were also investigated for
increased lovastatin production. Variations in pH affect transport of
molecules across cell membrane and suppression of fungal growth.
A pH of 6.0 was found to be suitable for lovastatin production in
A. terreus (KM017963) as compared to reports of pH 5.0 being
suitable in A. fischeri and A. flavipes (Valera et al. 2005; Chanakya
et al. 2011).ontrol: 2 g of wheat bran with relative humidity of 70%, pH 7.0, 107/8 spores/mL, 28 C,
Figure 9. Effect of sodium acetate on lovastatin production in A. terreus (L1). Control:
2 g of wheat bran with relative humidity of 70%, pH 7.0, 107/8 spores/mL, 28 C, 0.5 cm
particle size. DWS ¼ dry weight substrate.
Optimial conditions for maximal lovastatin production 179In mesophilic organisms the temperature between 26 C and
30 C significantly influences metabolite production, enzyme ac-
tivity, protein function and cell viability (Chanakya et al. 2011). Our
investigations on effect of temperature on lovastatin production are
in accordance to temperature of 30 C being most suitable for
lovastatin production as reported in A. fischeri and A. flavipes and
M. ruber (Valera et al. 2005; Xu et al. 2005; Chanakya et al. 2011).
Yield of lovastatin was observed to be optimum at 60% which is
reported to be suitable for lovastatin production (Xu et al. 2005;
Chanakya et al. 2011). As the moisture content increased, the
yield of lovastatin decreased correspondingly, presumably, because
of the aggregation of substrate particles, decrease of void volume
and thereby reducing the aeration, growth and metabolite pro-
duction (Jahromi et al. 2012). Under low moisture conditions, the
available oxygen is sufficient, but the water content is not enough
to support upright metabolic activity and heat dissipation (Valera
et al. 2005; Aparna and Reddy 2012). Inoculum volume governs
lovastatin titre. Higher volume causes rapid nutrient depletionFigure 10. Effect of amino acids on lovastatin production in A. terreus (L1). Control: 2 g of w
size. DWS ¼ dry weight substrate.before the completion of growth period, thus resulting in poor yield
of the product (Chanakya et al. 2011). Initial inoculum volume of
107 spores/mL gave the highest yield of lovastatin in A. terreus
(KM017963) which is the most widely reported spore volume
(Jaivel and Marimuthu 2010).
Surface area of the particle in solid substrate plays a major role
for initial attachment, accessibility of nutrients and subsequent
colonization by microbes. In our study, a particle size of 0.25 mm
was found to be optimum for lovastatin production. A particle size
of 0.4 mm was reported to be favourable for lovastatin production
on A. flavipes (Valera et al. 2005) whereas in A. terreus (KM017963)
0.5 mm particle size did not favour lovastatin production.
In lovastatin biosynthetic pathway, the enzyme diketide syn-
thase catalyses the attachment of 2 methyl butyric acid chain to
monacolin J and to form monacolin L. This enzyme is regulated by
the gene lovF. The function of lovF is enhanced in the presence of
divalent metal ions such as Zn or Fe in the medium (Jia et al. 2010).
Accordingly in our study, the metal ions such as sodium chloride,
copper sulphate, calcium chloride, ferrous sulphate and magne-
sium sulphate increased lovastatin yield by minimum of five fold
individually, but when supplemented in combination had moder-
ate inhibitory action on lovastatin production.
Surfactants play a vital role in altering cell membrane perme-
ability and to ease the passage of secondary metabolites in to the
external environment. Also, addition of hydrocarbons in general
when added as supplements under submerged growth condition
aids in oxygen supply, increased mycelial growth and product for-
mation. A significant increase in lovastatin yield by three fold
(940 mg/L) in SmF with supplementation of butyrolactone was
recorded (Bizukojc and Ledakowicz 2009). However, none of the
surfactants and hydrocarbons had any positive impact on lovastatin
production under SSF in our strain of A. terreus (KM017963).
Lovastatin biosynthetic pathway gets initiated with acetate
units being linked to each other in head-to-tail fashion to form two
polyketide chains. Later, the amino acid methionine donates its
methyl group to the growing chain and forms the functional lova-
statin (Osman et al. 2011). However, addition of sodium acetate and
amino acids did not have any effect on production of lovastatin in
A. terreus (KM017963).This implies that sodium acetate and aminoheat bran with relative humidity of 70%, pH 7.0, 107/8 spores/mL, 28 C, 0.5 cm particle
P.V. Kamath, et al180acids required for the biosynthetic pathway of cellular functions are
sufficiently produced by organisms when grown in SSF.
Very few reports are available on optimization of lovastatin
production under SSF and this study is one of the few. Some of the
essential nutrients available in solid substrate can be of sub-optimal
concentrations or absent. Basic supplementation of required nu-
trients could act as an inducer for growth and/or production of any
metabolite. Therefore, an attempt was made in this study to opti-
mize the solid substrate with varied supplements which resulted in
few significant findings which could be exploited for large scale
production of lovastatin in A. terreus under SSF.Conflict of interest
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